// App-Quantinova.ai

EXTH-07 : AN ANTISENSE OLIGONUCLEOTIDE AGAINST TUMOR MICROTUBES IN GLIOBLASTOMA AS A NEW THERAPEUTIC OPTION TO IMPROVE TUMOR SPECIFIC THERAPY

Researchers

Presenter

  • Sophie Weil

Principal Investigators

  • Daniel Domínguez Azorín

  • Erik Jung

  • Josie Higgins

  • Hafeez Mohammed

  • Jill Reckless

  • Nigel Ramsden

  • Peter Keller

  • David Grainger

  • Wolfgang Wick

  • Frank Winkler

Medical Centers

  • Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Baden-Wurttemberg, Germany

  • Divide & Conquer, Babraham, United Kingdom

Locations

  • Germany

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Glioblastoma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved